Abstract:Objective: Objective: In our study, we aimed to detect Ph (Philadelphia) chromosome and BCRABL fusion gene in 25 patients with CML (Chronic Myeloid Leukemia) by Cytogenetic Analysis and RT-PCR (Reverse Transcriptase Polymerase Chain Reaction). Materials and Methods: Bone marrow or blood samples were obtained from the patients included in our study. Total RNA was isolated from peripheral blood, bone marrow and cell lines using an RNA isolation kit. RNA purity was measured by spectrophotometer and RNAs of appropriate purity were selected for the study. cDNA synthesis was performed from mRNA using random hexamer primers and reverse transcriptase enzyme. Target DNA was amplified by the two-step Nested PCR method using oligonucleotide primers. The K562 cell line was used as a positive control and distilled water was used as a negative control. PCR products were run on agarose gel stained with ethidium bromide and displayed on the gel imaging system. Cell culture was made from bone marrow material over 24 hours for cytogenetic analysis. Microscopic examinations were performed by applying G-banding s to the preparations. Results: Ten female and 15 male patients were included in our study. The average age of the patient group was calculated as 53,24. According to the PCR results; M-BCR/ABL was negative in 5 patients and positive in 20 patients. In cytogenetic analysis, 20 metaphase areas were examined in each patient preparation. No growth occurred in 5 patients. 46,XY karyotype in 5 patients, 46,XX karyotype in one patient, 46,XY t (9; 22) (q34, q11) karyotype in 9 patients, and 46.XX (9; 22) (q34; q11) karyotype in 5 patients was found. The patients with no reproduction in cytogenetic analysis and negative for the Ph chromosome were examined by molecular analysis. M-BCR / ABL was positive in 6 patients. According to our results, it was found the M-BCR / ABL ratio was 20/25 (80%), and the Ph chromosome positivity rate was 80%. Conclusion: In CML disease, for monitoring diagnosis and treatment response, cytogenetic analysis and the faster and more sensitive RT-PCR technique were applied together and the results were examined.

Chronic myeloid leukemia with e14a3 BCR-ABL transcript: analysis of characteristics and prognostic significance.

[Cytogenetic and Molecular Analysis of 1193 Cases with Chronic Myeloid Leukemia].

Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population

Detection of FLT3/ITD, JAK2(V617F) and NPM1 gene mutations in chronic myelomonocytic leukemia

Cytogenetic Analysis of 1863 Chineses Patients with Chronic Myeloid Leukemia

Early BCR-ABL1 Decline in Imatinib-Treated Patients with Chronic Myeloid Leukemia: Results from a Multicenter Study of the Chinese CML Alliance

Characteristics and Outcome of Chromosomal Abnormalities in Ph Negative Cells of Chronic Myelogenous Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Chronic myeloid leukemia with two rare fusion gene transcripts of atypical BCR::ABL: A case report and literature review

Prevalence and Outcomes of Uncommon BCR‐ABL1 Fusion Transcripts in Patients with Chronic Myeloid Leukaemia: Data from a Single Centre

Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia

Cytogenetic analysis of 362 cases of chronic myeloid leukemia]

A Novel BCR::ABL1 Variant Detected with Multiple Testing Modalities

Breakpoint mapping of a t(9;22;12) chronic myeloid leukaemia patient with e14a3 BCR-ABL1 transcript using Nanopore sequencing

Distribution of BCR::ABL1 Transcripts in the Different Clinical Phases of Chronic Myeloid Leukemia: Effect on Hematological Parameters and Patient Survival

Molecular Detection of BCR-ABL in Chronic Myeloid Leukemia.

Laboratory Study on A Rare Case of Chronic Myeloid Leukemia with Ins(22;9)t(9;13)and Ph-negative

Analysis of Two Mutations in the BCR-ABL Fusion Gene Relevant for Monitoring Chronic Myeloid Leukemia Patients

Detection of Philadelphia Chromosome and BCR-ABL Fusion Gene in Patients with Chronic Myeloid Leukemia by Cytogenetic Analysis and RT-PCR Technique

Advantages of Digital PCR in the Detection of Low Abundance BCR-ABL1 Gene in Patients with Chronic Myeloid Leukemia

Chronic Myeloid Leukemia with a Rare Philadelphia Chromosome Variant Involving Chromosome 16

[Major molecular response to imatinib in a patient with acute mixed lineage leukemia expressing a novel BCR/ABL transcript].